Cargando…
USE OF THE PROSTATE HEALTH INDEX FOR DETECTION OF PROSTATE CANCER: RESULTS FROM A LARGE ACADEMIC PRACTICE
BACKGROUND: The Prostate Health Index (phi) outperforms PSA and other PSA derivatives for the diagnosis of prostate cancer (PCa). The impact of phi testing in the real-world clinical setting has not been previously assessed. METHODS: In a single, large, academic center, phi was tested in 345 patient...
Autores principales: | Tosoian, Jeffrey J., Druskin, Sasha C., Andreas, Darian, Mullane, Patrick, Chappidi, Meera, Joo, Sarah, Ghabili, Kamyar, Agostino, Joseph, Macura, Katarzyna J., Carter, H. Ballentine, Schaeffer, Edward M., Partin, Alan W., Sokoll, Lori J., Ross, Ashley E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429201/ https://www.ncbi.nlm.nih.gov/pubmed/28117387 http://dx.doi.org/10.1038/pcan.2016.72 |
Ejemplares similares
-
Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016) -
Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance
por: Tosoian, Jeffrey J., et al.
Publicado: (2017) -
Prostate MRI prior to radical prostatectomy: effects on nerve sparing and pathological margin status
por: Druskin, Sasha C, et al.
Publicado: (2017) -
Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy
por: Ross, Ashley E., et al.
Publicado: (2017) -
A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host
por: Simons, Brian W., et al.
Publicado: (2019)